Analgesics in the US - New Market Report

Self-medication is an extremely common practice in the United Arab Emirates and is prevalent among adults, teenagers and children. In particular, among young people who have less experience of suffering moderate pain, it has become quite common for them to take accidental overdoses of analgesics when self-medicating to relieve or reduce pain. In particular, several recent accidental overdoses of acetaminophen has raised concerns within the government of the United Arab Emirates about the safety of analgesics at a time when it taking steps to educate children of the importance of asking for advice from pharmacists and doctors before self-medicating with OTC analgesics.

Full Report Details at
- http://www.fastmr.com/prod/830203_analgesics_in_the_us.aspx?afid=301

Competitive Landscape

GlaxoSmithKline Plc led analgesics in the United Arab Emirates in 2013 with a 28% value share, while Julphar Gulf Pharmaceuticals was in second position with 12% and Abbott Laboratories (Saudi Arabia) held third position with a value share of 4%. GlaxoSmithKline remains the leading player in analgesics as it is able to take advantage of its strong image at global level and the positive image of its Panadol acetaminophen brand, which is very well-known in the United Arab Emirates. Julphar is the leading domestic company in analgesics and also maintains high levels of brand equity.

Industry Prospects

High levels of self-medication and the occasional abuse of OTC analgesics are likely to remain issues affecting the category during the forecast period, although to a lesser extent than during the review period as the government of the United Arab Emirates is expected to introduce new measures such as improvements to health education in order to combat this problem, especially with regards to children.

Report Overview

Discover the latest market trends and uncover sources of future market growth for the Analgesics industry in United Arab Emirates with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Analgesics industry in United Arab Emirates, our research will save you time and money while empowering you to make informed, profitable decisions.

The Analgesics in United Arab Emirates market research report includes:

* Analysis of key supply-side and demand trends
* Detailed segmentation of international and local products
* Historic volumes and values, company and brand market shares
* Five year forecasts of market trends and market growth
* Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

You may also be interested in these related reports:

- Analgesics in Israel
- Analgesics in Indonesia
- Analgesics in the United Kingdom
- Analgesics in South Korea
- Analgesics in India